Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.50 +0.01 (+2.17%)
As of: Oct 2, 2026 · 1:28 PM EDT

Pasithea Therapeutics (KTTA) Return on Equity [ROE] (2021 - 2026)

Updated

Pasithea Therapeutics (KTTA) recorded Return on Equity [ROE] of -40.69% in Q2 2026, up 54.89 percentage points from -95.58% a year earlier but down 4.82 percentage points from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Pasithea Therapeutics reported Return on Equity [ROE] of -58.36%, up 14.47 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a four-year change of -49.95 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -72.83% in FY2024 (-24.39 pp), -48.44% in FY2023 (-18.77 pp), -29.68% in FY2022 (-21.26 pp) and -8.41% in FY2021.
  • Quarterly Return on Equity [ROE] has ranged from -98.55% in Q3 2025 to -6.40% in Q4 2021 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +5.28 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 62.16 percentage points in Q1 2026, against a drop of 45.38 percentage points in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -35.87% (Q1 2026), -60.59% (Q4 2025) and -98.55% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - -40.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.69%
Mar 31, 2026 -35.87%
Dec 31, 2025 -60.59%
Sep 30, 2025 -98.55%
Jun 30, 2025 -95.58%
Mar 31, 2025 -98.03%
Dec 31, 2024 -85.31%
Sep 30, 2024 -92.83%
Jun 30, 2024 -90.90%
Mar 31, 2024 -75.25%
Dec 31, 2023 -61.66%
Sep 30, 2023 -50.13%
Jun 30, 2023 -45.51%
Mar 31, 2023 -38.95%
Dec 31, 2022 -31.95%
Sep 30, 2022 -17.36%
Jun 30, 2022 -10.77%
Mar 31, 2022 -6.95%
Dec 31, 2021 -6.40%
API Access

Pasithea Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KTTA&period=max&api_key=YOUR_API_KEY